Suchergebnisse - "Ghosh, Alakendu"

PubPharm (7)

1

Hepatic and hematological adverse effects of long-term low-dose methotrexate therapy in rheumatoid arthritis : An observational study

enthalten in: Indian journal of pharmacology | 2016

von Dubey, L. | Chatterjee, S. | Ghosh, A.

2

Itolizumab in combination with methotrexate modulates active rheumatoid arthritis : safety and efficacy from a phase 2, randomized, open-label, parallel-group, dose-ranging study

enthalten in: Clinical rheumatology | 2016

von Chopra, A. | Chandrashekara, S. | Iyer, R. | +10

3

Hepatic and hematological adverse effects of long-term low-dose methotrexate therapy in rheumatoid arthritis: An observational study

enthalten in: Indian journal of pharmacology | 2016

von Dubey, L. | Chatterjee, S. | Ghosh, A.

4

Itolizumab in combination with methotrexate modulates active rheumatoid arthritis: safety and efficacy from a phase 2, randomized, open-label, parallel-group, dose-ranging study

enthalten in: Clinical rheumatology | 2015

von Chopra, A. | Chandrashekara, S. | Iyer, R. | +10

5

Itolizumab in combination with methotrexate modulates active rheumatoid arthritis: safety and efficacy from a phase 2, randomized, open-label, parallel-group, dose-ranging study

enthalten in: Clinical rheumatology | 2015

von Chopra, A. | Chandrashekara, S. | Iyer, R. | +10

6

Itolizumab in combination with methotrexate modulates active rheumatoid arthritis: safety and efficacy from a phase 2, randomized, open-label, parallel-group, dose-ranging study

enthalten in: Clinical rheumatology | 2015

von Chopra, A. | Chandrashekara, S. | Iyer, R. | +10

7

Early, structured disease modifying anti-rheumatic drug (DMARD) therapy reduces cardiovascular risk in rheumatoid arthritis--a single centre study using non-biologic drugs

enthalten in: The Journal of the Association of Physicians of India | 2013

von Chatterjee, S. | Sarkate, P. | Ghosh, S. | +2

CommentIn: J Assoc Physicians India. 2013 Aug;61(8):529. - PMID 24818334

1
[1]